MedPageToday -- DENVER -- A novel anti-inflammatory drug significantly improved estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes and chronic kidney disease (CKD), results of a multicenter placebo-controlled trial showed.
MedPageToday -- DENVER -- A novel anti-inflammatory drug significantly improved estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes and chronic kidney disease (CKD), results of a multicenter placebo-controlled trial showed.